focus -WSS

focus

author：comprehensive 2025-09-29 01:37:54 - browse：18855

Balance innovation — Medicare laid out in the greatest detail yet how it will choose which drug prices it will negotiate in its brand-new program, and how it will figure out what the government’s opening offer will be. Adobe

WASHINGTON — Medicare laid out Wednesday in the greatest detail yet how it will choose which drug prices it will negotiate in its brand-new program, and how it will figure out what the government’s opening offer will be.

Democrats outlined some parts of the process in the Inflation Reduction Act that passed Congress last August, but the details of how drugs will be selected and what factors will be considered have been vague until now. Though the actual negotiated prices won’t take effect for years, Medicare officials must announce the first 10 drugs they’ll negotiate over by Sept. 1.

The guidance clarifies that the agency will choose the 50 pharmacy drugs that cost Medicare the most money, based on gross expenditures. If drugs have the same cost to the program, then the one that has been approved longer will be ranked higher.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： 'Cuddling' is just what the doctor ordered for a 200

Wikipedia

hotspot

WSS

Paxlovid should be available without a positive Covid test

Special counsel alerts court to Trump’s social media post

Rivals hope for voter 'fatigue' as Trump's woes mount but base stays loyal: ANALYSIS

Pharma needs to include young adults in clinical research

Rock icon Freddie Mercury pre

How the Dana

knowledge

focus

hotspot

Hollywood unions extend contract negotiations for actors

California Joshua trees severely burned in massive wildfire

Malaria cases in Florida and Texas: Here’s what you need to know

Teen charged with murder as hate crime in killing of NYC dancer O'Shae Sibley: Sources

The cancer drug shortage isn’t new — and neither are the solutions

Health tech startups drop sharply from 2021 highs

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Pope greeted like rockstar, appears revitalized at 'Catholic Woodstock' in Portugal

Apple is now the first public company to be valued at $3 trillion

How the Dana

knowledge

Scientists find bacteria from stomach of ancient iceman

Lifetime voting ban for felony convictions struck down in Mississippi

Jesse Tyler Ferguson makes friendship bracelets for Taylor Swift's Eras Tour

Menendez indictment could see pharma lose a key ally

Listen: Who gets the credit for GLP

Inequities make cancer less preventable for women: report

Wikipedia

hotspot

focus

focus